Form 8-K - Current report:
SEC Accession No. 0001104659-21-062471
Filing Date
2021-05-06
Accepted
2021-05-06 16:51:36
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115334-1_8k.htm   iXBRL 8-K 25807
2 EXHIBIT 99.1 tm2115334d1_ex99-1.htm EX-99.1 339194
6 GRAPHIC image_005.jpg GRAPHIC 4389
  Complete submission text file 0001104659-21-062471.txt   570497

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20210506.xsd EX-101.SCH 3175
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20210506_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20210506_pre.xml EX-101.PRE 22703
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115334-1_8k_htm.xml XML 3674
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 21898656
SIC: 2834 Pharmaceutical Preparations